Michele McCann Olbrys, PA

Michele Olbrys practices at Stamford Health Medical Group, Inc. in Stamford, Connecticut.

Michele Olbrys' NPI, 1164494407, was assigned on February 2, 2006. Michele Olbrys holds Connecticut license 001326.

Michele Olbrys' primary practice is Stamford Health Medical Group, Inc., at 1 Omega Dr, Stamford, CT 06907 in Western Ct County. The practice phone is (203) 276-7447.

Michele Olbrys' primary practice is Stamford Health Medical Group, Inc. in Stamford, Connecticut. Michele Olbrys is also affiliated with Stamford Hospital. The medical group on file is Stamford Health Medical Group. Dmand AI also links Michele Olbrys to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michele Olbrys practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Michele Olbrys' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michele Olbrys is licensed in Connecticut.

Dmand AI lists acute sinusitis, chest wall injury, chronic obstructive pulmonary disease (COPD), ear infection, fibromyalgia and chronic pain, fluid and electrolyte imbalances, gastroenteritis and lower back pain among the conditions Michele Olbrys treats.

CMS data shows 121 Medicare services from Michele Olbrys across 3 procedure codes in 2024, for 87 Medicare patients. Medicare paid $7,749 for them. Every service was in an office.

CMS counts 87 Medicare patients who saw Michele Olbrys in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 14% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michele Olbrys' median patient age at 56, with 65% women.

In 2024, Michele Olbrys wrote 597 Medicare Part D claims for 150 patients. 77% of them were for generic drugs. CMS names the drug for 278 of them, across 15 drugs with 11 or more claims each, at $75,306 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Michele Olbrys for performance year 2024, reported as part of a group. Michele Olbrys accepts Medicare assignment, so Medicare's approved amount is taken as full payment.